Clinical trial

Study on the Safety of Risperidone on Obese or Overweight Patients With Schizophrenia

NCT00511628

StatusTERMINATED

Study typeOBSERVATIONAL

Start date2001-07-01

PhaseN/A

Study timeline

Study start (unknown)2001-07-01Date precision: month

Registry last updated2011-05-19

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Schizophreniaunresolved

Schizoaffective Disorderunresolved

Schizophreniform Disorderunresolved

Interventions

RisperidoneDRUG · verified · RxNorm: risperidone

Sponsors & collaborators

Janssen-Cilag, S.A.lead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00511628 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.